Herpes zoster virus of shingles
About us We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.
Read morePress releases
- US FDA approves Krintafel (tafenoquine) for the radical cure of P. vivax malaria
- ViiV Healthcare shares data from landmark 2-drug regimen trials at AIDS 2018
- US FDA Advisory Committee endorses the effectiveness and safety of single-dose tafenoquine for the radical cure of P. vivax malaria
Tweets from GSK
-
GSK @GSK
#MondayMotivation from Alicia, one of our #HIV research scientists: "I’m motivated by the opportunity to investigate thought provoking questions and new directions that I hope could lead to new therapies - which will benefit HIV patients." #PLHIV
about 3 hours ago
-
GSK @GSK
Make sure you're following @ViiVHC for live updates from #AIDS2018 in Amsterdam twitter.com/ViiVHC/status/…
about 4 hours ago
-
GSK @GSK
#NEWS: Thanks to #FDA approval, @GSK and @MedsforMalaria will offer the first new medicine in over 60 years for relapsing #malaria.
about 1 day ago
